MX345820B - Formulacion del precursor de hidrogel y proceso de produccion del mismo. - Google Patents

Formulacion del precursor de hidrogel y proceso de produccion del mismo.

Info

Publication number
MX345820B
MX345820B MX2012012248A MX2012012248A MX345820B MX 345820 B MX345820 B MX 345820B MX 2012012248 A MX2012012248 A MX 2012012248A MX 2012012248 A MX2012012248 A MX 2012012248A MX 345820 B MX345820 B MX 345820B
Authority
MX
Mexico
Prior art keywords
precursor formulation
formulation
production process
hydrogel precursor
hydrogel
Prior art date
Application number
MX2012012248A
Other languages
English (en)
Other versions
MX2012012248A (es
Inventor
Rizzi Simone
Lutolf Matthias
Original Assignee
Qgel Sa *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qgel Sa * filed Critical Qgel Sa *
Publication of MX2012012248A publication Critical patent/MX2012012248A/es
Publication of MX345820B publication Critical patent/MX345820B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3344—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing oxygen in addition to sulfur
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a una formulación del precursor de hidrogel, su proceso de producción así como un kit que comprende tal formulación y un método de producción de un hidrogel usando tal formulación. La formulación del precursor comprende al menos un compuesto estructural, preferiblemente vinil sulfona (ramificada acrilada) poli(etilen glicol), y al menos un compuesto de ligadura, preferiblemente un péptido con dos cisteínas, en donde el compuesto estructural y el compuesto de ligadura son polimerizables por una reacción selectiva entre un nucleófilo y un grupo o enlace insaturado conjugado. La formulación del precursor está en la forma de un polvo.
MX2012012248A 2010-04-22 2011-04-19 Formulacion del precursor de hidrogel y proceso de produccion del mismo. MX345820B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10160796A EP2380920A1 (en) 2010-04-22 2010-04-22 Hydrogel precursor formulation and production process thereof
PCT/EP2011/056187 WO2011131642A1 (en) 2010-04-22 2011-04-19 Hydrogel precursor formulation and production process thereof

Publications (2)

Publication Number Publication Date
MX2012012248A MX2012012248A (es) 2012-11-23
MX345820B true MX345820B (es) 2017-02-16

Family

ID=42224660

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012248A MX345820B (es) 2010-04-22 2011-04-19 Formulacion del precursor de hidrogel y proceso de produccion del mismo.

Country Status (9)

Country Link
US (3) US20130040357A1 (es)
EP (2) EP2380920A1 (es)
JP (2) JP6185837B2 (es)
CN (1) CN102858845B (es)
AU (1) AU2011244362B2 (es)
BR (1) BR112012027053B1 (es)
MX (1) MX345820B (es)
RU (1) RU2561108C2 (es)
WO (1) WO2011131642A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888951B1 (fr) 2005-07-20 2008-02-08 Essilor Int Composant optique pixellise aleatoirement, son procede de fabrication, et son utilisation dans la fabrication d'un element optique transparent
US9719068B2 (en) 2010-05-06 2017-08-01 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US20150087725A1 (en) * 2011-12-02 2015-03-26 Hong Kong Universit of Science and Technology Injectable Gelling Material
EP2796873A1 (en) * 2013-04-25 2014-10-29 QGel SA Method for a cell-based drug screening assay and the use thereof
AU2015267148B2 (en) 2014-05-28 2021-07-29 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
EP3207123A1 (en) 2014-10-17 2017-08-23 Children's Hospital Center D/b/a Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
WO2017040989A1 (en) * 2015-09-04 2017-03-09 Saint Louis University Custom multiwell plate design for rapid preparation and assembly of photo-patterned hydrogels
CN116790476A (zh) 2016-05-05 2023-09-22 儿童医院医疗中心 用于体外制造胃底组织的方法和与其相关的组合物
EP3275997A1 (en) * 2016-07-28 2018-01-31 QGel SA Hydrogel precursor formulation and the use thereof
CA3045145A1 (en) 2016-12-05 2018-06-14 Children's Hospital Medical Center Colonic organoids and methods of making and using same
EP3789049A1 (en) 2019-09-06 2021-03-10 QGel SA Method for obtaining healthy intestinal organoids
JP2023505209A (ja) 2019-12-04 2023-02-08 プレシジョン・キャンサー・テクノロジーズ・インコーポレイテッド 細胞成長のための方法及びキット
CN113980292A (zh) * 2021-10-03 2022-01-28 淮阴工学院 一种新型生物相容性聚醚砜基水凝胶的制备方法
CN114652903A (zh) * 2022-05-06 2022-06-24 上海益思妙医疗器械有限公司 一种快速聚合医用水凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6703047B2 (en) * 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
ES2632564T3 (es) 1999-02-01 2017-09-14 Eidgenössische Technische Hochschule Zürich Bio-materiales formados por reacción de adición nucleófila a grupos insaturados conjugados
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
JP2003505471A (ja) 1999-07-21 2003-02-12 アムジエン・インコーポレーテツド Ｖｇｆポリペプチドおよびｖｇｆ関連障害の治療方法
DK1218437T3 (da) * 1999-08-27 2009-10-19 Angiodevice Internat Gmbh Præparater, som danner interpenetrerende polymernetværk, til anvendelse som medicinske tætningsmidler med höj styrke
CA2466116C (en) * 2001-11-07 2012-04-24 Universitat Zurich Synthetic matrix for controlled cell ingrowth and tissue regeneration
SE0403014D0 (sv) * 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
EP1828244A2 (en) * 2004-12-22 2007-09-05 Kuros Biosurgery AG Michael-type addition reaction functionalised peg hydrogels with factor xiiia incorporated biofactors
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
CA2677532A1 (en) 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
US20090042825A1 (en) 2007-08-06 2009-02-12 Majed Matar Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
US9125814B2 (en) * 2008-04-22 2015-09-08 Angiotech Pharmaceuticals, Inc. Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same

Also Published As

Publication number Publication date
CN102858845A (zh) 2013-01-02
MX2012012248A (es) 2012-11-23
EP2561005B1 (en) 2016-11-09
US20150247119A1 (en) 2015-09-03
US20130040357A1 (en) 2013-02-14
WO2011131642A1 (en) 2011-10-27
RU2561108C2 (ru) 2015-08-20
BR112012027053A2 (pt) 2016-07-19
US20180119092A1 (en) 2018-05-03
BR112012027053B1 (pt) 2020-03-03
US9850461B2 (en) 2017-12-26
JP6185837B2 (ja) 2017-08-23
CN102858845B (zh) 2017-05-03
JP2016033139A (ja) 2016-03-10
AU2011244362B2 (en) 2014-12-04
EP2380920A1 (en) 2011-10-26
AU2011244362A1 (en) 2012-11-15
JP2013531691A (ja) 2013-08-08
EP2561005A1 (en) 2013-02-27
RU2012149729A (ru) 2014-05-27

Similar Documents

Publication Publication Date Title
MX345820B (es) Formulacion del precursor de hidrogel y proceso de produccion del mismo.
WO2014097099A3 (en) Glycoconjugation process
EP2677029A3 (en) Methods for the manufacture of proteolytically processed polypeptides
WO2013049227A3 (en) High efficiency, small volume nucleic acid synthesis
PH12015500465A1 (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
NZ700181A (en) Plant cytochrome p450
WO2014028453A3 (en) Natural killer cells and uses thereof
WO2014092886A3 (en) Pairing code directed assembly
MX344246B (es) Procedimiento para la preparacion de cloruros de acido 5-fluoro-1-alquil-3-fluoroalquil-1h-pirazol-4-carboxilico.
WO2007147004A3 (en) Differentiation of multi-lineage progenitor cells to hepatocytes
ATE527266T1 (de) Herstellungsverfahren für asenapin und in diesem verfahren verwendete zwischenprodukte
WO2011089595A3 (en) Sustained-release nucleic acid matrix compositions
WO2014017493A9 (ja) ワクチン
WO2014036445A3 (en) Novel mucolytic agents
SG164381A1 (en) Enzymatic production of (meth)acrylic acid esters
WO2011121051A3 (fr) Preparation issue d'une culture in vitro de cellules dedifferenciees non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention
EP2405551A3 (en) Ring power distribution loop
MX366795B (es) Polimero multietapa como aditivo de molienda, y metodo para producir el mismo.
AR086860A1 (es) Proceso para la produccion de propenos clorados y/o fluorados
EP2314275A3 (en) Compositions comprising a low-dp polymerized surfactant and a micellar thickener
WO2014179648A3 (en) Direct anti-markovnikov addition of acids to alkenes
WO2010133289A3 (de) Terminal ungesättigte, oxetan-basierte makromonomere und verfahren zu deren herstellung
WO2013121279A3 (en) Process to prepare ertapenem
WO2013012839A8 (en) Reactive dyes for contact lenses
WO2009098147A3 (en) Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids

Legal Events

Date Code Title Description
FG Grant or registration